WELCOME TO THE HOME OF THE mNRA TECHNOLOGY TRANSFER HUB

AFRIGEN BIOLOGICS AND VACCINES IS

a Cape Town based biotechnology company strategically directed, supported and capitalized by Avacare Healthcare Group and the Industrial Development Corporation (IDC) of South Africa. It was founded in 2014 by Steven G. Reed (PhD) and Erik Iverson (JD, LLM), both of the Infectious Diseases Research Institute (IDRI) www.idri.org in Seattle. Afrigen drives a business strategy focussing on product development, bulk adjuvant manufacturing, and supply and distribution of key biologicals to address unmet healthcare needs.

OUR PRODUCTS

Creating products with the aim of positively impacting the lives of both humans and animals reflects a commitment to societal and environmental well-being. It's crucial to prioritize quality and ethical standards in product creation, ensuring that they not only serve their intended purpose effectively but also contribute to the greater good. Whether it's through innovation, sustainability, or promoting well-being, such endeavors can make a meaningful difference in the world.

OUR SERVICES

OUR BRANDS

AFRIGEN IS MAKING HEADLINES

Please see below articles on where we have been featuring world wide. Be sure to visit our social pages for more updates.

October 9, 2023